Stereoselective chromatography of cardiovascular drugs: An update

Journal of Biochemical and Biophysical Methods

Volumn 54, Issue 1-3, 2002, Pages 197-220

  Bojarski, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Blockers; Adrenoceptor agonists; Antiarrhythmic drugs; Calcium channel blockers; Cardiovascular drugs; Enantiomer separation

Indexed keywords

ACEBUTOLOL; ALPRENOLOL; AMLODIPINE; AROTINOLOL; ATENOLOL; BETAXOLOL; BISOPROLOL; BUCUMOLOL; BUFURALOL; BUPRANOLOL; CARBUTEROL; CARTEOLOL; CARVEDILOL; CLENBUTEROL; CLEVIDIPINE; DIPRAFENONE; DISOPYRAMIDE; FELODIPINE; FLECAINIDE; MANIDIPINE; MEXILETINE; NICARDIPINE; NIMODIPINE; NISOLDIPINE; PROPAFENONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; CHIRALITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; SEPARATION TECHNIQUE; STEREOCHEMISTRY; THIN LAYER CHROMATOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; BRONCHODILATOR AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CHROMATOGRAPHY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PHARMACOLOGY, CLINICAL; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM;

EID: 0037207264     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(02)00143-4     Document Type: Article

References (218)

1. Thomas R.E. Cardiac drugs. Wolff M. Burger's medicinal chemistry and drug discovery. vol. 2:1996;153-261 Wiley, New York.
2. Ruffolo R.R. Jr. Stereoselectivity in adrenergic agonists and adrenergic blocking agents. Ariëns E.J., Soudijn W., Timmermans P.B.M.W.M. Stereochemistry and biological activity of drugs. 1983;103-125 Blackwell, Oxford.
3. Wainer I.W., Alembik M.C. The enantiomeric resolution of biologically active molecules on commercially available liquid chromatographic chiral stationary phase. Zief M., Crane L.J. Chromatographic chiral separations. 1988;355-384 Marcel Dekker, New York.
4. Levin S., Abu-Lafi S. The role of enantioselective liquid chromatographic separations using chiral stationary phases in pharmaceutical analysis. Brown P.R., Grushka E. Advances in chromatography. vol. 33:1993;233-266 Marcel Dekker, New York.
5. Šubert J. Progress in the separation of enantiomers of chiral drugs by HPLC without prior derivatization. Pharmazie. 49:1994;3-13.
6. Bojarski J., Aboul-Enein H.Y. Recent applications of chromatographic resolution of enantiomers in pharmaceutical analysis. Biomed. Chromatogr. 10:1996;297-302.
7. Šubert J., Šlais K. Progress in the separation of enantiomers of chiral drugs by TLC without their prior derivatization. Pharmazie. 56:2001;355-360.
8. Bojarski J., Aboul-Enein H.Y. Recent chromatographic and electrophoretic enantioseparations of cardiovascular drugs. Biomed. Chromatogr. 13:1999;197-208.
9. Egginger G., Lindner W., Vandenbosch C., Massart D.L. Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol. Biomed. Chromatogr. 7:1993;277-295.
10. Vandenbosch C., Massart D.L., Egginger G., Lindner W. Liquid chromatographic methods for the chiral separation of β-adrenergic blocking agents. Trends Anal. Chem. 12:1993;168-177.
11. Kleidernigg O.P., Lindner W. Synthesis of new stable aliphatic isocyanate-based chiral derivatizing agent and application to indirect separation of chiral amino and thio compounds. Chromatographia. 44:1997;465-472.
12. Toyo'oka T., Toriumi M., Ishii Y. Enantioseparation of β-blockers labelled with a chiral fluorescent reagent, R(-)-DBD-PyNCS by reversed-phase liquid chromatography. J. Pharm. Biomed. Anal. 15:1997;1467-1476.
13. Toyo'oka T., Jin D., Tomoi N., Oe T., Hiranuma H. (R)-(-)-4-(3-isothiocyanatopyrrolidin-1-yl)-7-(N,N-dimethylaminosulfonyl)-2, 1,3-benzoxadiazole, a fluorescent chiral tagging reagent: sensitive resolution of chiral amines and amino acids by reversed-phase liquid chromatography. Biomed. Chromatogr. 15:2001;56-67.
14. Kim K.H., Choi P.W., Hong S.-P., Kim H.J. Chiral separation of β-blockers after derivatization with (-)-methyl chloroformate by reversed-phase high-performance liquid chromatography. Arch. Pharm. Res. 22:1999;608-613.
15. Kim K.H., Choi P.W., Hong S.-P., Kim H.J. Chiral purity test of metoprolol enantiomer after derivatization with (-)-methyl chloroformate by reversed-phase high-performance liquid chromatography. Arch. Pharm. Res. 22:1999;614-618.
16. Beal J.L., Tett S.E. Determination of pindolol enantiomers in human plasma and urine by simple liquid-liquid extraction and high-performance liquid chromatography. J. Chromatogr. B. 715:1998;409-415.
17. Li X., Yao T.-W., Zeng S. Reversed-phase high-performance liquid chromatographic analysis of atenolol enantiomers in rat hepatic microsome after chiral derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glycopyranosyl isothiocyanate. J. Chromatogr. B. 742:2000;433-439.
18. Péter M., Gyéresi A., Fülöp F. Liquid chromatographic enantioseparation of β-blocking agents with (1R,2R)-1,3-diacetoxy-1-(4-nitrophenyl)-2-propyl isothiocyanate as chiral derivatizing agent. J. Chromatogr. A. 910:2001;247-253.
19. Srinivas N.R. Selection of internal standard for quantitative analysis of enantiomers following precolumn chiral derivatization. J. Chromatogr. B. 709:1998;321-323.
20. Szymura-Oleksiak J., Walczak M., Bojarski J., Aboul-Enein H.Y. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum. Chirality. 11:1999;267-271.
21. Fornstedt T., Hesselgren A.-M., Johansson M. Chiral assay of atenolol present in microdialysis and plasma samples of rats using chiral CBH as stationary phase. Chirality. 9:1997;329-334.
22. Lamprecht G., Kraushofer T., Stoschitzky K., Lindner W. Enantioselective analysis of (R)- and (S)-atenolol in urine samples by a high-performance liquid chromatography column-switching setup. J. Chromatogr. B. 740:2000;219-226.
23. Mišlanowá C., Štefancová A., Oravcová J., Horecký J., Trnovec T., Lindner W. Direct high-performance liquid chromatographic determination of (R)- and (S)-propranolol in rat microdialysate using on-line column switching procedures. J. Chromatogr. B. 739:2000;151-161.
24. Aboul-Enein H.Y., Bakr S.A. Enantiomeric resolution of propranolol and analogs on two cellulose (Chiralcel OF and OC) and one amylose (Chiralpak AD) chiral stationary phases. J. Liq. Chromatogr. Relat. Technol. 21:1998;1137-1145.
25. Suede R., Srichana T., Martin G.P. Evaluation of matrices containing molecularly imprinted polymers in the enantioselective-controlled delivery of β-blockers. J. Control. Release. 66:2000;135-147.
26. M. McCullagh, Rao R., Bickerstaffe S., Bayliss M. Extending the performance of LC/MS to chiral separations, Int. Lab. 2000;30:5A, 6.
27. Kim K.H., Kim H.J., Kang J.-S., Mar W. Determination of metoprolol enantiomers in human urine by coupled achiral-chiral chromatography. J. Pharm. Biomed. Anal. 22:2000;377-384.
28. Kim K.H., Shin S.D., Lee J.H., Lee S.C., Kang J.S., Mar W.et al. Chiral separation of enantiomers of metoprolol and its metabolites by high performance liquid chromatography. Arch. Pharm. Res. 23:2000;230-236.
29. Jung S.H., Linh P.T., Lim H.K., Kim H.J., Kim K.H., Kang J.S. Enantioselective preparation of metoprolol and its major metabolites. Arch. Pharm. Res. 23:2000;226-229.
30. Lanchote V.L., Bonato P.S., Cerqueira P.M., Pereira V.A., Cesarino E.J. Enantioselective analysis of metoprolol in plasma using high-performance liquid chromatographic and indirect separations: applications in pharmacokinetics. J. Chromatogr. B. 738:2000;27-37.
31. Mistry B., Leslie J.L., Eddington N.D. Enantiomeric separation of metoprolol and α-hydroxymetoprolol by liquid chromatography and fluorescence detection using a chiral stationary phase. J. Chromatogr. B. 758:2001;153-161.
32. Ikegawa S., Matsuura K., Sato T., Isriyanthi N.M.R., Niwa T., Miyari S.et al. Enantioselective immunoaffinity extraction for simultaneous determination of optically active bufuralol and its metabolites in human plasma by HPLC. J. Pharm. Biomed. Anal. 17:1998;1-9.
33. Yang X., Fukushima T., Santa T., Homma H., Imai K. Enantiomeric separation and sensitive detection of propranolol, metoprolol and atenolol derivatized with a fluorogenic reagent, 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulfonyl-2,1,3- benzoxadiazole (DBD-COCl), on cellulose chiral columns in the reversed-phase mode. Analyst. 122:1997;1365-1369.
34. Dakers J.M., Boulton D.W., Fawcett J.P. Sensitive chiral high-performance liquid chromatographic assay for labetalol in biological fluids. J. Chromatogr. B. 704:1997;215-220.
35. Aboul-Enein H.Y., Al-Durabi I.A. Isocratic HPLC separation of several racemic drugs with two stereogenic centers on a Pirkle urea-type chiral stationary phase. J. Liq. Chromatogr. Relat. Technol. 21:1998;1817-1831.
36. Bazylak G., Aboul-Enein H.Y. Direct separation of labetalol stereoisomers in high performance liquid chromatography system using helically self-assembled chelate as chiral selector in the mobile phase. J. Liq. Chromatogr. Relat. Technol. 22:1999;1171-1192.
37. Ferretti R., Gallinella B., La Torre F., Zanitti L. Direct resolution of isamoltane (CGP 361A) and enciprazine (WY 48624) enantiomers, using chiral high performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 22:1999;1877-1892.
38. Götmar G., Fornstedt T., Guiochon G. Apparent and true enantioselectivity in enantioseparations. Chirality. 12:2000;558-564.
39. Götmar G., Fornstedt T., Andersson M., Guiochon G. Influence of the solute hydrophobicity on the enantioselective adsorption of β-blockers on a cellulase protein used as the chiral selector. J. Chromatogr. A. 905:2001;3-17.
40. Stahlberg J., Henriksson H., Divne C., Isaksson R., Pettersson G., Johansson G.et al. Structural basis for enantiomer binding and separation of a common β-blocker: crystal structure of cellobiohydrolase Cel7A with bound (S)-propranolol at 1.9 A resolution. J. Mol. Biol. 305:2001;79-93.
41. Williams K.L., Sander L.C., Wise S.A. Comparison of liquid and supercritical fluid chromatography for the separation of enantiomers on chiral stationary phases. J. Pharm. Biomed. Anal. 15:1997;1789-1799.
42. Phinney K.W., Sander L.C., Wise S.A. Coupled achiral/chiral column techniques in subcritical fluid chromatography for the separation of chiral and nonchiral compounds. Anal. Chem. 70:1998;2331-2335.
43. Huang M.-B., Li G.-L., Yang G.-S., Shi Y.-H., Gao J.J., Liu X.-D. Enantiomeric separation of aromatic amino alcohol drugs by chiral ion-pair chromatography on a silica gel plate. J. Liq. Chromatogr. Relat. Technol. 20:1997;1507-1514.
44. Bushan R., Thuku Thiongo G.J. Direct enantioseparation of some β-adrenergic blocking agents using impregnated thin-layer chromatography. J. Chromatogr. B. 708:1998;330-334.
45. Toussaint B., Duchateau A.L.L., van der Wal S., Albert A., Hubert Ph., Crommen J. Determination of the enantiomers of 3-tert-butylamino-1,2-propanediol by high-performance liquid chromatography coupled to evaporative light scattering detection. J. Chromatogr. A. 890:2000;239-249.
46. Toussaint B., Streel B., Ceccato A., Hubert Ph., Crommen J. Determination of the enantiomers of 3-tert-butylamino-1,2-propanediol by high-performance liquid chromatography using mass spectrometric detection. J. Chromatogr. A. 896:2000;201-207.
47. Kim K.H., Yun H.W., Kim H.J., Park H.J., Choi P.W. Coupled chiral chromatography in chiral separation of salmeterol. Arch. Pharm. Res. 21:1998;212-216.
48. Kim K.H., Kim T.K. Resolution of salbutamol enantiomers in human urine by reversed-phase high-performance liquid chromatography after derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranose isothiocyanate. Arch. Pharm. Res. 21:1998;217-222.
49. Bergés R., Segura J., de la Torre X., Ventura R. Analytical methodology for enantiomers of salbutamol in human urine for application in doping control. J. Chromatogr. B. 723:1999;173-184.
50. Fried K.M., Koch P., Wainer I.W. Determination of the enantiomers of albuterol in human and canine plasma by enantioselective high-performance liquid chromatography on a teicoplanin-based chiral stationary phase. Chirality. 10:1998;484-491.
51. Bazylak G., Aboul-Enein H.Y. In situ arrangement of supramolecules throughout direct separation of carbuterol enantiomers in RP-HPLC system with helical additives in mobile phase. Anal. Lett. 32:1999;521-551.
52. Bazylak G., Aboul-Enein H.Y. Supramolecular effects in chiral discrimination of clenbuterol enantiomers in RP-HPLC system with helically self-assembled mobile-phase additive. Retention studies and molecular modeling approach. Chirality. 11:1999;387-393.
53. Smith D.J. Stereochemical composition of clenbuterol residues in edible tissues of swine. J. Agric. Food Chem. 48:2000;6036-6043.
54. Aboul-Enein H.Y., Serignese V. Optimized enantioselective separation of clenbuterol on macrocyclic antibiotic teicoplanin chiral stationary phase. J. Liq. Chromatogr. Relat. Technol. 22:1999;2177-2185.
55. Aboul-Enein H.Y., Serignese V. Quantitative determination of clenbuterol enantiomers in human plasma by high-performance liquid chromatography using the macrocyclic antibiotic chiral stationary phase teicoplanin. Biomed. Chromatogr. 13:1999;520-524.
56. Kim K.H., Kim D.S., Hong S.-P., Keon O.S. Reversed-phase high performance liquid chromatographic separations of the enantiomers of terbutaline by derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate. Arch. Pharm. Res. 23:2000;26-30.
57. 1H-NHM and RP-LC using chiral derivatizing agent, (S)-(-)-α-methylbenzyl isocyanate. J. Pharm. Biomed. Anal. 25:2001;947-956.
58. Kim K.H., Kim H.J., Kim J.H., Lee J.H., Lee S.C. High-performance liquid chromatographic and capillary electrophoretic methods for the quantitation of the (S)-terbutaline in (R)-terbutaline. Chromatographia. 53:2001;334-337.
59. Kim K.H., Kim H.J., Kim J.-H., Shin S.D. Determination of terbutaline enantiomers in human urine by coupled achiral-chiral high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. 751:2001;69-77.
60. Lanchote V.L., Bonato P.S., Cesarino E.J., Mere Y.A. Jr., Cavani S.R., Santos J.et al. Enantioselective determination of the hydroxylated metabolites of mexiletine in human plasma. Chirality. 9:1997;732-738.
61. Zhong D., Chen R., Fieger-Büschges H., Blume H. Enantioselective determination of diprafenone in human plasma. Pharmazie. 52:1997;106-109.
62. Yao T.W., Zhou Q., Zeng S. Stereoselective determination of propafenone enantiomers in transgenic Chinese hamster CHL cells expressing human cytochrome P450. Biomed. Chromatogr. 14:2000;498-501.
63. de Gaitani C.M., Lanchote V.L., Bonato P.S. Enantioselective analysis of propafenone in plasma using a polysaccharide-based chiral stationary phase under reversed-phase conditions. J. Chromatogr. B. 708:1998;177-183.
64. Zhong D., Chen X. Enantioselective determination of propafenone and its metabolites in human plasma by liquid chromatography-mass spectrometry. J. Chromatogr. B. 721:1999;67-75.
65. de Abreu L.R.P., Lanchote V.L., Bertucci C., Cesarino E.J., Bonato P.S. Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived stationary phase. J. Pharm. Biomed. Anal. 20:1999;209-216.
66. Bonato P.S., de Abreu L.R.P., de Gaitani C.M., Lanchote V.L., Bertucci C. Enantioselective HPLC analysis of propafenone and of its main metabolites using polysaccharide and protein based chiral stationary phases. Biomed. Chromatogr. 14:2000;227-233.
67. Bortocan R., Lanchote V.L., Cesarino E.J., Bonato P.S. Enantioselective analysis of disopyramide and N-monodealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase. J. Chromatogr. B. 744:2000;299-306.
68. Bonato P.S., Lanchote V.L., Bortocan R., Jabor V.A.P., Paias F.O., Ricci-Júnior E.et al. Chiral stationary phases based on cellulose and amylose tris-3,5-dimethylphenylcarbamate derivatives for the resolution of selected chiral drugs and metabolites. J. Liq. Chromatogr. Relat. Technol. 22:1999;1813-1827.
69. Hanada K., Akimoto S., Mitsui K., Hashiguchi M., Ogata H. Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. J. Chromatogr. B. 710:1998;129-135.
70. Rustichelli C., Ferioli V., Gamberini G. Resolution of the enantiomers of verapamil and gallopamil by chiral liquid chromatography-mass spectrometry. Chromatographia. 44:1997;477-483.
71. Sandström R., Lennernäs H., Öhlén K., Karlsson A. Enantiomeric separation of verapamil and norverapamil using Chiral-AGP® as the stationary phase. J. Pharm. Biomed. Anal. 21:1999;43-49.
72. Asafu-Adjaye E.B., Shiu G.K. Solid-phase extraction-high-performance liquid chromatography determination of verapamil and norverapamil enantiomers in urine. J. Chromatogr. B. 707:1998;161-167.
73. Brandšteterova E., Wainer I.W. Achiral and chiral high-performance liquid chromatography of verapamil and its metabolites in serum samples. J. Chromatogr. B. 732:1999;395-404.
74. Ho P.C., Saville D.J., Wanwimolruk S. Simultaneous HPLC analysis of S- and R-verapamil and metabolites, S- and R-norverapamil in human plasma. J. Liq. Chromatogr. Relat. Technol. 23:2000;1711-1723.
75. Brandšteterova E., Wainer I.W., Tracy T. Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples. Neoplasma. 46:1999;207-211.
76. Fried K., Wainer I.W. Column-switching techniques in the biomedical analysis of stereoisomeric drugs: why, how and when. J. Chromatogr. B. 689:1997;91-104.
77. Tokuma Y., Noguchi H. Stereoselective pharmacokinetics of dihydropyridine calcium antagonists. J. Chromatogr. A. 694:1995;181-193.
78. Uno T., Ohkubo T., Sugawara K. Enantioselective high-performance liquid chromatographic determination of nicardipine in human plasma. J. Chromatogr. B. 698:1997;181-186.
79. Uno T., Ohkubo T., Sugawara K. Enantioselective high-performance liquid chromatographic determination of manidipine in human plasma. J. Liq. Chromatogr. Relat. Technol. 22:1999;1117-1128.
80. Owens P.K., Fell A.F., Coleman M.W., Berridge J.C. Effect of charged and uncharged chiral additives on the resolution of amlodipine enantiomers in liquid chromatography and capillary electrophoresis. J. Chromatogr. A. 797:1998;187-195.
81. Lukša J., Josic D., Podobnik B., Furlan M., Kremser J. Semi-preparative chromatographic purification of the enantiomers of S-(-) amlodipine and R-(+) amlodipine. J. Chromatogr. B. 639:1997;367-375.
82. Lukša J., Josic D., Kremser J., Kopitar Z., Milutinovic S. Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration. J. Chromatogr. B. 703:1997;185-193.
83. Ericsson H., Schwieler J., Lindmark B., Löfdahl P., Thulin T., Regardh C.G. Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. Chirality. 13:2001;130-134.
84. Gyllenhaal O., Karlsson A. Enantioresolution of dihydropyridine substituted acid by supercritical fluid chromatography on Hypercarb® with Z-(L)-arginine as chiral counter ion. Chromatographia. 52:2000;351-355.
85. Karlsson A., Nyström A. Addition of organic modifiers to control retention order of enantiomers of dihydropyridines on chiral-AGP. Chromatographia. 53:2001;135-139.
86. Marques M.P., Santos N.A.G., Coelho E.B., Bonato P.S., Lanchote V.L. Enantioselective assay of nisoldipine in human plasma by chiral high-performance liquid chromatography combined with gas-chromatographic-mass spectrometry: applications to pharmacokinetics. J. Chromatogr. B. 762:2001;87-95.
87. Rask H., Angelo H.R., Christensen H.R. Enantioselective determination of isradipine in human serum using chiral stationary phase liquid chromatography and gas chromatography with nitrogen selective detection. Chirality. 10:1998;808-812.
88. Mielcarek J. Normal-phase TLC separation of enantiomers of 1,4-dihydropyrimidine derivatives. Drug Dev. Ind. Pharm. 27:2001;175-179.
89. Yaku K., Aoe K., Nishimura N., Sato T., Morishita F. Chiral resolution of four optical isomers of diltiazem hydrochloride on Chiralcel columns by packed-column supercritical fluid chromatography. J. Chromatogr. A. 785:1997;185-193.
90. Yaku K., Aoe K., Nishimura N., Sato T., Morishita F. Direct chiral resolution of optical isomers of diltiazem hydrochloride by packed column supercritical fluid chromatography. Williams J.R., Clifford A.A. Supercritical fluid methods and protocols. 2000;149-156 Humana Press, Totowa, NJ.
91. Rodriguez Rosas M.E., Shibukawa A., Ueda K., Nakagawa T. Enantioselective protein binding of semotiadil and levosemotiadil determined by high-performance frontal analysis. J. Pharm. Biomed. Anal. 15:1997;1595-1601.
92. 5,9]undecane (NGP-1-01). Pharmazie. 53:1998;859-862.
93. Saraç S., Yarym M., Ertan M. Analytical resolution of 4-aryl-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thiones using a cellulose chiral stationary phase. Anal. Lett. 32:1999;1245-1254.
94. Takahashi H., Kashima T., Kimura S., Muramoto N., Nakahata H., Kubo S.et al. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet detection or fluorescence and on-line circular dichroism detection. J. Chromatogr. B. 701:1997;71-80.
95. Henne K.R., Gaedigk A., Gupta G., Leeder J.S., Rettie A.E. Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype. J. Chromatogr. B. 710:1998;143-148.
96. Prangle A.S., Noctor T.A.G., Lough W.J. Chiral bioanalysis of warfarin using microbore LC with peak compression. J. Pharm. Biomed. Anal. 16:1998;1205-1212.
97. Ring P.R., Bostick J.M. Validation of a method for the determination of (R)-warfarin and (S)-warfarin in human plasma using LC with UV detection. J. Pharm. Biomed. Anal. 22:2000;573-581.
98. Naidong W., Ring P.R., Midtlien C., Jiang X. Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma. J. Pharm. Biomed. Anal. 25:2001;219-226.
99. Bertucci C., Andrisano V., Cavrini V., Castiglioni E. Reliable assay of extreme enantiomeric purity values by a new circular dichroism based HPLC detection system. Chirality. 12:2000;84-92.
100. Rentsch K.M., Gutteck-Amsler U., Bührer R., Fattinger K.E., Vonderschmitt D.J. Sensitive stereospecific determination of acenocoumarol and phenprocoumon in plasma by high-performance liquid chromatography. J. Chromatogr. B. 742:2000;131-142.
101. Cirilli R., La Torre F. Stereoselective analysis of benazepril and its stereoisomers by reversed-phase high-performance liquid chromatography on a chiral AGP column. J. Chromatogr. A. 818:1998;53-60.
102. Cirilli R., Di Bugno C., La Torre F. Stereoselective analysis of idrapril and its stereoisomers by reversed-phase high-performance liquid chromatography on a chiral AGP column. Chromatographia. 49:1999;628-634.
103. Owens P.K., Svensson L.A., Vessman J. Direct separation of captopril diastereoisomers including their rotational isomers by RP-LC using a teicoplanin column. J. Pharm. Biomed. Anal. 25:2001;453-464.
104. Herráez-Hernández R., Campíns-Falcó P. Chromatographic separation of chlorthalidone enantiomers using β-cyclodextrins as chiral additives. J. Chromatogr. B. 740:2000;169-177.
105. Salvador A., Herbreteau B., Dreux M., Karlsson A., Gyllenhaal O. Chiral supercritical fluid chromatography on porous graphitic carbon using commercial dimethyl β-cyclodextrins as mobile phase additive. J. Chromatogr. A. 929:2001;101-112.
106. Arai K., Jin D., Kusu F., Takamura K. Determination of p-hydroxymandelic acid enantiomers in urine by high-performance liquid chromatography with electrochemical detection. J. Pharm. Biomed. Anal. 15:1997;1509-1514.
107. Hefnawy M.M., Stewart J.T. HPLC separation of metyrosine enantiomers as methyl esters derivatized with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate. J. Liq. Chromatogr. Relat. Technol. 21:1998;381-389.
108. Van Dort M.E. Direct chromatographic resolution and isolation of the four stereoisomers of meta-hydroxyphenylpropanolamine. Chirality. 11:1999;684-688.
109. Cerqueira P.M., Mateus F.H., Cesarino E.J., Bonato P.S., Lanchote V.L. Enantioselectivity of debrisoquine 4-hydroxylation in Brazilian Caucasian hypertensive patients phenotyped as extensive metabolizers. J. Chromatogr. B. 749:2000;153-161.
110. McAleer S.D., Foondun A.S., Feely M., Chrystyn H. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients. Chirality. 9:1997;13-16.
111. Yoshigae Y., Imai T., Horita A., Otagiri M. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver. Chirality. 9:1997;661-666.
112. Freitag D.G., Foster R.T., Coutts R.T., Pickard M.A., Pasutto F.M. Stereoselective metabolism of rac-mexiletine by the fungus cunninghamella echinulata yields the major human metabolites hydroxymethylmexiletine and p-hydroxymexiletine. Drug Metab. Dispos. 25:1997;685-692.
113. Janiczek N., Smith D.E., Chang T., Ventura A., Mertz T.E. Pharmacokinetics and pharmacodynamics of pirmentol enantiomers in coronary artery ligated dogs. J. Pharm. Sci. 86:1997;443-449.
114. Horikiri Y., Suzuki T., Mizobe M. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs. J. Pharm. Sci. 86:1997;560-564.
115. Horikiri Y., Suzuki T., Mizobe M. Pharmacokinetics and metabolism of bisoprolol enantiomers in humans. J. Pharm. Sci. 87:1998;289-294.
116. Horikiri Y., Suzuki T., Mizobe M. Stereoselective metabolism of bisoprolol enantiomers in dogs and humans. Life Sci. 63:1998;1097-1108.
117. Paradiso-Hardy F.L., Walker S.E., Bowles S.K. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers. Int. J. Clin. Pharmacol. Ther. 36:1998;370-375.
118. Huang Y.F., Upton R.N., Zheng D., McLean C., Gray E.C., Grant C. The enantiomer-specific kinetics and dynamics of verapamil after rapid intravenous administration to sheep: physiological analysis and modeling. J. Pharmacol. Exp. Ther. 284:1998;1048-1057.
119. Mostafavi S.A., Foster R.T. Pharmacokinetics of single oral and multiple intravenous and oral administration of acebutolol enantiomers in a rat model. Biopharm. Drug Dispos. 19:1998;425-431.
120. Labbé L., Abolfathi Z., Robitaille N.M., St-Maurice F., Gilbert M., Turgeon J. Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine. Ther. Drug Monit. 21:1999;191-199.
121. Lanchote L.V., Cesarino E.J., Santos V.J., Mere Y. Jr., Santos S.R.C.J. Enantioselectivity in the metabolism of mexiletine by conjugation in female patients with the arrhythmic form of chronic Chagas' heart disease. Chirality. 11:1999;29-32.
122. Lanchote L.V., Santos V.J., Cesarino E.J., Dreossi S.A.C., Mere Y. Jr., Santos S.R.C.J. Enantioselective analysis of N-hydroxymexiletine glucuronide in human plasma for pharmacokinetic studies. Chirality. 11:1999;85-90.
123. Cerqueira P.M., Cesarino E.J., Mateus F.H., Mere Y. Jr., Santos S.R.C.J., Lanchote V.R. Enantioselectivity in the steady-state pharmacokinetics of metoprolol in hypertensive patients. Chirality. 11:1999;591-597.
124. 3 cells. Eur. J. Pharmacol. 376:1999;169-178.
125. Johnson J.A., Akers W.S., Herring V.L., Wolfe M.S., Sullivan J.M. Gender differences in labetalol kinetics: importance of determining stereoisomer kinetics for racemic drugs. Pharmacotherapy. 20:2000;622-628.
126. Chen X., Zhong D., Blume H. Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers. Eur. J. Pharm. Sci. 10:2000;11-16.
127. Von Deutsch D.A., Abukhalaf I.K., Wineski L.E., Aboul-Enein H.Y., Pitts S.A., Parks B.A.et al. β-Agonist-induced alterations in organ weights and protein content: comparison of racemic clenbuterol and its enantiomers. Chirality. 12:2000;637-648.
128. Wanner-Olsen H., Gaarskaer F.B., Mikkelsen E.O., Jacobsen P., Voldby B. Studies on concentration-time profiles of nimodipine enantiomers following intravenous and oral administration of nimodipine in patients with subarachnoid hemorrhage. Chirality. 12:2000;660-664.
129. Mori Y., Hanada K., Mori T., Tsukahara Y., Hashiguchi M., Ogata H. Stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil in rabbits. Biol. Pharm. Bull. 24:2001;806-810.
130. Narimatsu S., Kobayashi N., Asaoka K., Masubuchi Y., Horie T., Hosokawa M.et al. High performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol. Chirality. 13:2001;140-147.
131. Suedee R., Brain K.R., Heard C.M. Enantioselective retardation of rac-propranolol from matrices containing cellulose derivatives. Chirality. 9:1997;307-312.
132. Suedee R., Brain K.R., Heard C.M. Differential permeation of propranolol across human skin in vitro from formulations containing an enantioselective excipient. Chirality. 11:1999;680-683.
133. 1H-NMR study. Drug Dev. Ind. Pharm. 27:2001;457-464.
134. Udata C., Tirucherai G., Mitra A.K. Synthesis, stereoselective enzymatic hydrolysis, and skin permeation of diastereomeric propranolol ester prodrugs. J. Pharm. Sci. 88:1999;544-550.
135. Carocci A., Franchini C., Lentini G., Loiodice F., Tortorella V. Facile entry to (-)-(R)- and (+)-(S)-mexiletine. Chirality. 12:2000;103-106.
136. Campo C., Llama E.F., Bermúdez J.L., Sinisterra J.V. Methodologies for the stereoselective synthesis of adrenergic β-blockers: an overview. Biocatal. Biotransform. 19:2001;163-180.
137. Grieb S.J., Matlin S.A., Belenguer A.M. Flash chiral chromatography with cellulose tris(3,5-dimethylplenylcarbamate)-coated phases. Improved resolution of basic analytes. J. Chromatogr. A. 728:1996;195-199.
138. Francotte E.R., Richert P. Applications of simulated moving-bed chromatography to the separation of the enantiomers of chiral drugs. J. Chromatogr. A. 769:1997;101-107.
139. Geiser F., Schultz M., Betz L., Shaimi M., Lee J., Champion W. Jr. Direct, preparative enantioselective chromatography of propranolol hydrochloride and thioridazine hydrochloride using carbon dioxide-based mobile phases. J. Chromatogr. A. 865:1999;227-233.
140. Chassaing C., Thienpont A., Felix G. Regioselective carbamoylated and benzoylated cellulose for the separation of enantiomers in high-performance liquid chromatography. J. Chromatogr. A. 738:1996;157-167.
141. Minguillón C., Franco P., Oliveros L., López P. Bonded cellulose-derived high-performance liquid chromatography chiral stationary phases: I. Influence of the degree of fixation on selectivity. J. Chromatogr. A. 728:1996;407-414.
142. Minguillón C., Franco P., Oliveros L. Bonded cellulose-derived high-performance liquid chromatography chiral stationary phases: II. Influence of the porosity of the silica gel matrix on performance. J. Chromatogr. A. 728:1996;415-422.
143. Franco P., Minguillón C., Oliveros L. Solvent versatility of bonded chiral stationary phases for high-performance liquid chromatography and its consequences in column loadability. J. Chromatogr. A. 793:1998;239-247.
144. Ringo M.C., Evans C.E. Pressure-induced changes in chiral separations in liquid chromatography. Anal. Chem. 69:1997;4964-4971.
145. Franco P., Minguillón C., Oliveros L. Bonded cellulose-derived high-performance liquid chromatography chiral stationary phases: III. Effect of the reticulation of the cellulose derivative on performance. J. Chromatogr. A. 791:1997;37-44.
146. Oliveros L., Senso A., Franco P., Minguillón C. Carbamates of cellulose bonded on silica gel: chiral discrimination ability as HPLC chiral stationary phases. Chirality. 10:1998;283-288.
147. Franco P., Senso A., Minguillón C., Oliveros L. 3,5-Dimethylphenylcarbamates of amylose, chitosan and cellulose bonded to silica gel. Comparison of their chiral recognition abilities as high-performance liquid chromatography stationary phases. J. Chromatogr. A. 796:1998;265-272.
148. Hou J.G., Wang Y.L., Li C.X., Han X.Q., Gao J.Z., Kang J.W. Reversed-phase separations on cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phase. Chromatographia. 50:1999;89-95.
149. Cass Q.B., Tiritan M.E., Calafatti S.A., Matlin S.A. Enantioseparation on amylose tris(3,5-dimethoxyphenyl carbamate): application to commercial pharmaceutical chiral drugs. J. Liq. Chromatogr. Relat. Technol. 22:1999;3091-3099.
150. Chankvetadze B., Yamamoto C., Okamoto Y. Enantioseparations using cellulose tris(3,5dichlorophenylcarbamate) during high-performance liquid chromatography with analytical capillary columns: potential for screening of chiral drugs. Combin. Chem. High Throughput Screen. 3:2000;497-508.
151. Ching C.B., Fu P., Ng S.C., Xu Y.K. Effect of mobile phase composition on the separation of propranolol enantiomers using a perphenylcarbamate β-cyclodextrin bonded chiral stationary phase. J. Chromatogr. A. 898:2000;53-61.
152. Castells C.B., Carr P.W. Fast separations of basic analytes by high-performance liquid chromatography using cellulose tris(3,5-dimethylphenylcarbamate)-coated zirconia stationary phases. J. Chromatogr. A. 904:2000;17-33.
153. Guillaume M., Jaulmes A., Sébille B., Thuaud N., Vidal-Madjar C. Study of the retention properties of warfarin enantiomers on a β-cyclodextrin polymeric support. J. Chromatogr. B. 753:2001;131-138.
154. Ekborg-Ott K.H., Liu Y., Armstrong D.W. Highly selective HPLC separations using the covalently bonded macrocyclic antibiotic, ristocetin A, chiral stationary phase. Chirality. 10:1998;434-483.
155. Ekborg-Ott K.H., Kullman J.P., Wang X., Gahm K., He L., Armstrong D.W. Evaluation of the macrocyclic antibiotic avoparcin as a new chiral selector for HPLC. Chirality. 10:1998;627-660.
156. Svensson L.A., Dönnecke J., Karlsson K.-E., Karlsson A., Vessman J. Vancomycin-based chiral stationary phases for micro-column liquid chromatography. Chirality. 11:1999;121-128.
157. Svensson L.A., Owens P.K. Enantioselective supercritical fluid chromatography using ristocetin A chiral stationary phases. Analyst. 125:2000;1037-1039.
158. Berthod A., Chen X., Kullman J.P., Armstrong D.W., Gasparrini F., D'Acquarica I.et al. Role of the carbohydrate moieties in chiral recognition on teicoplanin-based LC stationary phases. Anal. Chem. 72:2000;1767-1780.
159. Svensson L.A., Dönnecke J., Karlsson K.-E., Karlsson A., Vessman J. Polar organic phase liquid chromatography with packed capillary columns using a vancomycic chiral stationary phase. Chirality. 12:2000;606-613.
160. Berthod A., Yu T., Kullman J.P., Armstrong D.W., Gasparrini F., D'Acquarica I.et al. Evaluation of the macrocyclic glycopeptide A-40,926 as a high-performance liquid chromatographic chiral selector and comparison with teicoplanin chiral stationary phase. J. Chromatogr. A. 897:2000;113-129.
161. Gottfries J., Johansson P., Karlsson A. Influence of chromatographic descriptors on enantioresolution of a dihydropyridine and structurally related compounds. J. Chromatogr. A. 763:1997;115-123.
162. Haginaka J., Kanasugi N. Enantioselectivity of bovine serum albumin-bonded columns produced with isolated protein fragments: II. Characterization of protein fragments and chiral binding sites. J. Chromatogr. A. 769:1997;215-223.
163. Millot M.C., Sébille B., Mangin C. Enantiomeric properties of human albumin immobilized on porous silica supports coated with polymethacryloyl chloride. J. Chromatogr. A. 776:1997;37-44.
164. Bertucci C., Wainer I.W. Improved chromatographic performance of a modified human albumin based stationary phase. Chirality. 9:1997;335-340.
165. Zou H., Wang H., Zhang Y. Stereoselective binding of warfarin and ketoprofen to human serum albumin determined by microdialysis combined with HPLC. J. Liq. Chromatogr. Relat. Technol. 21:1998;2663-2674.
166. Ascoli G.A., Bertucci C., Salvadori P. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions. Biomed. Chromatogr. 12:1998;248-254.
167. Bertucci C., Canepa A., Ascoli G.A., Lopes Guimaraes L.F., Felix G. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin. Chirality 1999;11:248.
168. Millot M.C., Loehman L., Sébille B., Hommel H. Chromatographic properties of chiral stationary phases based on human serum albumin. Influence of the polymer sublayer. Chromatographia. 50:1999;641-648.
169. Bertucci C., Andrisano V., Gotti R., Cavrini V. Development of a disulfiram-modified human serum albumin-based HPLC column. Chromatographia. 52:2000;319-324.
170. Zhang Q., Zou H., Wang H., Ni J. Synthesis of a silica-bonded bovine serum albumin s-triazine chiral stationary phase for high-performance liquid chromatographic resolution of enantiomers. J. Chromatogr. A. 866:2000;173-181.
171. Bertucci C., Andrisano V., Gotti R., Cavrini V. Modulation of chromatographic performances of HSA-based HPLC column by reversible binding of lithocholic acid. Chromatographia. 53:2001;515-518.
172. De Lorenzi E., Massolini G., Lloyd D.K., Monaco H.L., Galbusera C., Caccialanza G. Evaluation of quail egg white riboflavin binding protein as a chiral selector in high-performance liquid chromatography and capillary electrophoresis. J. Chromatogr. A. 790:1997;47-64.
173. 1-acid-glycoprotein stationary phase. J. Liq. Chromatogr. Relat. Technol. 21:1998;2535-2547.
174. Massolini G., De Lorenzi E., Lloyd D.K., McGann A.M., Caccialanza G. Evaluation of β-lactoglobulin as a stationary phase in high-performance liquid chromatography and as a buffer additive in capillary electrophoresis: observation of a surprising lack of stereoselectivity. J. Chromatogr. B. 712:1998;83-94.
175. Hedeland M., Jönsson S., Isaksson R., Pettersson C. Unexpected difference in enantioselective retention on cellulase (CBH I) silica stationary phase caused by exchange of potassium for sodium ion in the mobile phase. Chirality. 10:1998;513-518.
176. Haque A., Stewart J.T. Chiral separations of selected pharmaceuticals on avidin column. J. Liq. Chromatogr. Relat. Technol. 21:1998;2675-2687.
177. 1-glycoprotein acid as chiral selector in the enantioseparation of midodrine and deglymidodrine racemates by HPLC. J. Pharm. Biomed. Anal. 18:1998;171-177.
178. Hedeland M., Isaksson R., Pettersson C. Cellobiohydrolase I as a chiral additive in capillary electrophoresis and liquid chromatography. J. Chromatogr. A. 807:1998;297-305.
179. 1-acid-glycoprotein column. J. Chromatogr. A. 818:1998;43-52.
180. Félix G., Descorps V. Stereochemical resolution of racemates, in HPLC, using a chiral stationary phase based upon immobilized α-chymotrypsin: I. Structural chiral separations. Chromatographia. 49:1999;595-605.
181. Haginaka J., Okazaki Y., Matsunaga H. Separation of enantiomers on a chiral stationary phase based on ovoglycoprotein. J. Chromatogr. A. 840:1999;171-181.
182. Henriksson H., Pettersson G., Johansson G. Discrimination between enantioselective and non-selective binding sites on cellobiohydrolase-based stationary phases by site specific competing ligands. J. Chromatogr. A. 857:1999.
183. Fulde K., Frahm A.W. Temperature-induced inversion of elution order in the enantioseparation of sotalol on a cellobiohydrolase I-based stationary phase. J. Chromatogr. A. 858:1999;33-43.
184. Haginaka J., Kagawa C., Matsunaga H. Separation of enantiomers on a chiral stationary phase based on ovoglycoprotein: VII. Comparison of chiral recognition ability of ovoglycoprotein from chicken and Japanese quail egg whites. J. Chromatogr. A. 858:1999;155-165.
185. Hedeland M., Holmin S., Nygard M., Pettersson C. Chromatographic evaluation of structure selective and enantioselective retention of amines and acids on cellobiohydrolase I wild type and its mutant D214N. J. Chromatogr. A. 864:1999;1-16.
186. Fornstedt T., Götmar G., Andersson M., Guiochon G. Dependence on the mobile phase pH of the adsorption behavior of propranolol enantiomers on a cellulase protein used as the chiral selector. J. Am. Chem. Soc. 121:1999;1164-1174.
187. Massolini G., De Lorenzi E., Calleri E., Tabolotti E., Caccialanza G. Chromatographic investigation on the binding site characteristic of quail egg-white riboflavin binding protein as a chiral stationary phase. J. Chromatogr. B. 738:2000;343-355.
188. Haginaka J., Matsunaga H., Kakehi K. Separation of enantiomers on a chiral stationary phase based on ovoglycoprotein: VIII. Chiral recognition ability of partially and completely deglycosylated ovoglycoprotein. J. Chromatogr. B. 745:2000;149-159.
189. 1-acid-glycoprotein HPLC columns: relationships with different scales of lipophilicity. Helv. Chim. Acta. 83:2000;767-776.
190. Götmar G., Fornstedt T., Guiochon G. Retention mechanism of β-blockers on an immobilized cellulase. Relative importance of the hydrophobic and ionic contributions to their enantioselective and nonselective interactions. Anal. Chem. 72:2000;3908-3915.
191. Henriksson H., Munoz I.G., Isaksson R., Pettersson G., Johansson G. Cellobiohydrolase 58 (P.c. Cel 7D) is complementary to the homologous CBH I (T.r. Cel 7A) in enantioseparations. J. Chromatogr. A. 898:2000;63-74.
192. Senso A., Oliveros L., Minguillón C. Chitosan derivatives as chiral selectors bonded on allyl silica gel: preparation, characterisation and study of the resulting high-performance liquid chromatography chiral stationary phases. J. Chromatogr. A. 839:1999;15-21.
193. Vaton-Chanvrier L., Bucaille N., Combret Y., Combret J.-C. Comparison of grafting modes for the preparation of cholic acid-based stationary phases. Influence on enantiomer separations in high-performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 23:2000;2155-2167.
194. Haginaka J., Sakai Y. Uniform-sized molecularly imprinted polymer material for (S)-propranolol. J. Pharm. Biomed. Anal. 22:2000;899-907.
195. Ellwanger A., Owens P.K., Karlsson L., Bayoudh S., Cormack P., Sherrington D.et al. Application of molecularly imprinted polymers in supercritical fluid chromatography. J. Chromatogr. A. 897:2000;317-327.
196. Kontrec D., Vinković V., Šunjić V. Preparation and evaluation of the chiral stationary phases based on N-4-(2,5,6-trichloro-1,3-dicyano)-phenyl derivatives of L-α-amino acids. J. Liq. Chromatogr. Relat. Technol. 23:2000;1203-1215.
197. Schmid M.G., Gecse O., Szabo Z., Kilar F., Gübitz G., Ali I.et al. Comparative study of the chiral resolution of beta-blockers on cellulose tris (3,5-dimethylphenylcarbamate) phases in normal and reversed phase modes. J. Liq. Chromatogr. Relat. Technol. 24:2001;2493-2504.
198. Chilmonczyk Z., Ksycinska H., Aboul-Enein H.Y., Lee W.J. Enantiomeric separation of some clinically used racemic drugs on Pirkle-1J chiral stationary phase. J. Liq. Chromatogr. Relat. Technol. 24:2001;2505-2512.
199. De Lorenzi E., Massolini G. Riboflavin binding proteins as chiral selectors in HPLC and CE. Pharm. Sci. Technol. Today. 2:1999;352-364.
200. Tachibana K., Ohnishi A. Reversed-phase liquid chromatographic separation of enantiomers on polysaccharide type chiral stationary phases. J. Chromatogr. A. 906:2001;127-154.
201. Felix G. Regioselectively modified polysaccharide derivatives as chiral stationary phases in high-performance liquid chromatography. J. Chromatogr. A. 906:2001;171-184.
202. Aboul-Enein H.Y. High-performance liquid chromatographic enantioseparation of drugs containing multiple chiral centers on polysaccharide-type chiral stationary phases. J. Chromatogr. A. 906:2001;185-193.
203. Karlsson A., Karlsson O. Enantiomeric separation of amino alcohols using Z-L-Glu-L-Pro or Z-L-Glu-D-Pro as a chiral counter ions and hypercarb as the solid phase. Chirality. 9:1997;650-655.
204. Svensson S., Vessman J., Karlsson A. Direct high-performance liquid chromatographic separations of metoprolol analogues on a Chiralcel OD column using chemometrics. J. Chromatogr. A. 839:1999;23-39.
205. Nyström A., Strandberg A., Aspegren A., Behr S., Karlsson A. Use of immobilized amyloglucosidase as chiral selector in chromatography. Immobilization and performance in liquid chromatography. Chromatographia. 50:1999;209-214.
206. Strandberg A., Nyström A., Behr S., Karlsson A. Use of immobilized amyloglucosidase as chiral selector in chromatography. Control of enantioselective retention and resolution in liquid chromatography. Chromatographia. 50:1999;215-222.
207. Karlsson A., Aspegren A. Enantiomeric separation of amino alcohols on protein phases using statistical experimental desing. A comparative study. J. Chromatogr. A. 866:2000;15-23.
208. Svensson S., Karlsson A., Gyllenhaal O., Vessman J. Chiral separation of metoprolol and some analogs with carbon dioxide on Chiralcel OD and Chiralpak AD stationary phases. Use of chemometrics. Chromatographia. 51:2000;283-293.
209. Karlsson A., Karlsson O. Chiral ion-pair chromatography on porous graphitized carbon using N-blocked dipeptides as counter ions. J. Chromatogr. A. 905:2001;329-335.
210. Kleidernigg O.P., Kappe C.O. Separation of enantiomers of 4-aryldihydropyrimidines by direct enantioselective HPLC. A critical comparison of chiral stationary phases. Tetrahedron: Asymmetry. 8:1997;2057-2067.
211. Lehotay J., Hroboňová K., Cižmárik J., Celková H. Separation of enantiomers of some 1,4-piperazine derivatives of aryloxyaminopropanols on a vancomycin chiral stationary phase. Pharmazie. 54:1999;743-745.
212. Hroboňová K., Lehotay J., Cižmáriková J., Armstrong D.W. Study of the mechanism of enantioseparation: I. Chiral analysis of alkylamino derivatives of aryloxypropanols by HPLC using macrocyclic antibiotics as chiral selectors. J. Liq. Chromatogr. Relat. Technol. 24:2001;2225-2237.
213. Aboul-Enein H.Y., Ali I. HPLC enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases. Pharmazie. 56:2001;214-216.
214. Brandšteterova E., Endresz G., Blaschke G. Chiral separation of verapamil and some of its metabolites by HPLC and CE. Pharmazie. 56:2001;536-541.
215. Abe I., Terada K., Nakahara T. Enantiomer separation of pharmaceuticals by capillary gas chromatography with novel chiral stationary phases. Biomed. Chromatogr. 14:2000;125-129.
216. Mehvar R., Jamali F. Bioequivalence of chiral drugs. Clin. Pharmacokinet. 33:1997;122-141.
217. Stoschitzky K., Lindner W. Time to reassess chiral aspects of β-adrenoceptor antagonists. Trends Pharmacol. Sci. 18:1997;306-307.
218. 2-adrenoceptor agonists: is there a cause for concern? J. Allergy Clin. Immunol. 103:1999;742-748.